The new standard in airborne infection control
The ShareGuard99® is an innovative medical device for respiratory infectious patient isolation. It is designed to reduce and prevent the transmission of airborne diseases in healthcare facilities by reducing the spread of aerosols and droplets caused by the patient and treatment measures (e.g., suction of mucus, non-invasive ventilation, etc.). It is fully compatible with other care equipment, such as oxygen therapy and patient monitoring devices.
A standardised and qualified medical device in Europe.
Patent pending innovation.
Infectious viruses are enriched in small aerosols, where they can stay airborne for hours and travel several meters. These aerosols are able to travel furthest into the airways, causing infection.
Pathogens that spread via respiratory aerosols:
The highest level of infection control
Prevent over 99% of aerosols from ever entering the air
The ShareGuard99® air purifier and isolation system is proven to prevent > 99%² of exhaled aerosols from entering the room air, equivalent to FFP3.
ShareGuard99® significantly reduces the risk of infection via airborne transmission, compared to the standalone use of PPE.
Allows airborne infection isolation rooms (AIIR) to be kept available e.g. for immunosuppressed patients.
Cuts down the need for cohort and allows for better utilisation of space and human resources.
EASY TO USE
Intuitive and simple functionality.
Non-obtrusive and rounded design allows for safe patient care. Easy removal in emergency situations.
A standardised and qualified medical device.
LOW TO NO MAINTENANCE
6 months continuous run time.
Purifier with >99% capture efficiency and >99.95% filtration efficiency.
Fits onto hospital beds that are 700–900mm (27–35’’) in width.
At 49 dBA, the ShareGuard99® is as quiet as a standard refrigerator.
Developed by a team of medical device experts and health care professionals.Learn more
The ShareGuard99® requires minimal maintenance on a day-to-day basis and can run continuously for 6 months until the filter needs to be replaced.
Support from the EU and Business Finland
Cooperation with Business Finland has played a significant role in the development of the ShareGuard99®. Business Finland has been supporting the first 9 months of the innovation’s R&D phase.
In August 2021, the Häme Centre for Economic Development, Transport and the Environment granted the project a state grant under the Act on State Aid for Business Development (9/2014). EU programme: Sustainable growth and jobs 2014-2020 – Structural Funds Programme of Finland.
We’re happy to assist you in any way. Please fill in the contact form below or contact us directly through the provided information. We will get back to you within one business day.
Martinsyrjäntie 8 A305810 HyvinkääFinland
+358 (0)19 414 581
We are on a mission to help professionals save more lives, more efficiently and safely.
Learn more about Sharkmedical Innovations
Be the first to hear about the launch of new products and other exciting news by subscribing to our newsletter. Enter your email address below to join!